Download presentation
Presentation is loading. Please wait.
Published byHelen Shaw Modified over 5 years ago
1
LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI LI-RADS version 2018 (v2018) had higher sensitivity for categorization of hepatocellular carcinomas (HCCs) as LR-5 on gadoxetate disodium–enhanced MRI vs LI-RADS version 2017 (v2017) (81% vs 68% respectively; P < .001). For small HCCs (10–19 mm), LI-RADS v2018 had higher sensitivity than LI-RADS v2017 (76% vs 11% respectively; P < .001). LR-5 criteria of LI-RADS v2018 had lower specificity than LI-RADS v2017 for diagnosis of small HCCs (10–19 mm) (94% vs 99%, respectively; P = .013). Axial images of gadoxetate-enhanced MRI in a 62-year-old man with chronic hepatitis B and HCC. Left – arterial phase; right – transitional phase. LR-5 nodule. Lee SM et al. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI. Published Online: July 16,
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.